カテゴリ： MarketLine, アメリカ, 企業調査

CME Group Inc.：戦略・SWOT・企業財務分析

◆英語タイトル：CME Group Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8014938
◆発行会社（調査会社）：MarketLine
◆発行日：2017年11月12日
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：金融サービス
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

CME Group Inc. – Strategy, SWOT and Corporate Finance Report
Summary

CME Group Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

CME Group Inc (CME), formerly Chicago Mercantile Exchange Holdings Inc., is a publicly traded financial services group. The group offers trading services to individuals, institutions and companies. It offers futures and options products availability on all exchanges. It operates exchanges for trading of asset classes which include futures, and options on futures based on agricultural commodities, equity indexes, foreign exchange, interest rates and alternative investments such as real estate and weather. Additionally, CME operates CME Clearing, a central counterparty clearing providers, which offers clearing and settlement services across asset classes for exchange-traded contracts and over-the-counter derivatives transactions. The group has a presence in the US, the UK, Singapore, Japan, Brazil, Canada, Hong Kong, China and South Korea. CME is headquartered in Chicago in Illinois, the US.

Scope

- Detailed information on CME Group Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting CME Group Inc. in the form of a SWOT analysis
- An in-depth view of the business model of CME Group Inc. including a breakdown and examination of key business segments
- Intelligence on CME Group Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about CME Group Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of CME Group Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess CME Group Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on CME Group Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
CME Group Inc.: Company Overview
CME Group Inc.: Overview and Key Facts
CME Group Inc.: Overview
CME Group Inc.: Key Facts
CME Group Inc.: Key Employees
CME Group Inc.: Key Employee Biographies
CME Group Inc.: Major Products and Services
CME Group Inc.: Company History
CME Group Inc.: Management Statement
CME Group Inc.: Locations and Subsidiaries
CME Group Inc.: Key Competitors
CME Group Inc.: Company Analysis
CME Group Inc.: Business Description
CME Group Inc.: SWOT Analysis
CME Group Inc.: SWOT Overview
CME Group Inc.: Strengths
CME Group Inc.: Weaknesses
CME Group Inc.: Opportunities
CME Group Inc.: Threats
CME Group Inc.: Corporate Financial Deals Activity
CME Group Inc.: Financial Deals Overview
CME Group Inc.: Targets and Partners
CME Group Inc.: Top Deals 2013 – 2017YTD*
CME Group Inc.: Advisors
CME Group Inc.: Top Legal Advisors
CME Group Inc.: Top Financial Advisors
CME Group Inc.: Mergers and Acquisitions
CME Group Inc.: Corporate Venturing
CME Group Inc.: Partnership
CME Group Inc.: Divestments
CME Group Inc.: Recent Developments
CME Group Inc.: News and Events Summary
CME Group Inc.: Business Expansion
CME Group Inc.: Contracts
CME Group Inc.: Corporate Governance
CME Group Inc.: Financial Deals
CME Group Inc.: Financial Performance
CME Group Inc.: Regulatory and Legal Events
CME Group Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: CME Group Inc.: Key Facts
Table 2: CME Group Inc.: Key Employees
Table 3: CME Group Inc.: Locations and Subsidiaries
Table 4: CME Group Inc.: Key Competitors
Table 5: CME Group Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: CME Group Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: CME Group Inc.: M&A Average Deal Size - Value (US$m)
Table 8: CME Group Inc.: Targets and Partners
Table 9: CME Group Inc.: Top Deals 2013 - 2017YTD*
Table 10: CME Group Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: CME Group Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: CME Group Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 13: CME Group Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 14: CME Group Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 15: CME Group Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 16: CME Group Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 17: CME Group Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 18: CME Group Inc.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 19: CME Group Inc.: News and Events Summary
Table 20: CME Group Inc.: Business Expansion
Table 21: CME Group Inc.: Contracts
Table 22: CME Group Inc.: Corporate Governance
Table 23: CME Group Inc.: Financial Deals
Table 24: CME Group Inc.: Financial Performance
Table 25: CME Group Inc.: Regulatory and Legal Events
Table 26: CME Group Inc.: Strategy and Operations

★海外企業調査レポート[CME Group Inc.：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Straumann Holding AG (STMN)：医療機器：M&Aディール及び事業提携情報
    Summary Straumann Holding AG (Straumann) is a provider of tooth replacement and orthodontic solutions. The company researches, develops, manufactures and markets dental implants, instruments, digital equipment, CADCAM prosthetics, dental biomaterials, software and clear aligners for application in t …
  • HTG Molecular Diagnostics Inc (HTGM)：医療機器：M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Triangle Capital Corp：企業のM&A・事業提携・投資動向
    Triangle Capital Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triangle Capital Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • The Abraaj Group-エネルギー分野：企業M&A・提携分析
    Summary The Abraaj Group (Abraaj) is a financial service provider that offers private equity, investment and credit strategies for real estate operations. The company helps companies in their operational improvements, management incentives, optimization of capital structure and the use of leverage. …
  • Petroleos de Venezuela SA-エネルギー分野：企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • AEON Co Ltd (8267)：企業の戦略的SWOT分析
    AEON Co Ltd (8267) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • KUKA AG (KU2)：企業の財務・戦略的SWOT分析
    KUKA AG (KU2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Chegg, Inc.：企業のM&A・事業提携・投資動向
    Chegg, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chegg, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • OncoSec Medical Inc (ONCS)-製薬・医療分野：企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Kasbah Resources Limited：戦略・SWOT・企業財務分析
    Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Goodwin Biotechnology Inc-製薬・医療分野：企業M&A・提携分析
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic …
  • BlueScope Steel Ltd：企業のM&A・事業提携・投資動向
    BlueScope Steel Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlueScope Steel Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • inVentiv Health Inc-製薬・医療分野：企業M&A・提携分析
    Summary inVentiv Health Inc (inVentiv) is a Clinical Research Organization (CRO) and Contract Commercial Organization (CCO). The company offers a broad range of clinical development and commercialization services develop and marketing their products and services. Few of its service offerings include …
  • CA Technologies, Inc.：企業の戦略・SWOT・財務情報
    CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Exeltis Pharmaceuticals Holding SL：製薬・医療：M&Aディール及び事業提携情報
    Summary Exeltis Pharmaceuticals Holding SL (Exeltis), a subsidiary of Insud Pharma, is a developer, producer, and marketer of medicinal products and medical devices. The company provides products in the therapeutic areas including women’s health, dermatology, respiratory, central nervous system, inf …
  • Entegris Inc (ENTG)：企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • HUYA Bioscience International LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary HUYA Bioscience International LLC (HUYA) is a biopharmaceutical company that develops early and late-stage drug candidates. The company’s pipeline products include HBI-8000, HBI-3000, and HBI-3802. Its HBI-8000 is a novel oral inhibitor of histone deacetylases; HBI-3000 is a channel blocker …
  • Recordati Rare Diseases Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Recordati Rare Diseases Inc (RRD), a subsidiary of Recordati SpA is a biopharmaceutical company that discovers and develops orphan drugs and biologics. The company’s products comprise chemet, neoprofen, panhematin, desoxyn, mustargen, carbaglu, cosmegen, peganone and tranxene, among others. …
  • Goodman Group：企業のM&A・事業提携・投資動向
    Goodman Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goodman Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Bayshore Petroleum Corp (BSH)：石油・ガス：M&Aディール及び事業提携情報
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. Its CCC technology provides heavy oil and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆